CdGAP/ARHGAP31, a Cdc42/Rac1 GTPase regulator, is critical for vascular development and VEGF-mediated angiogenesis-Reference-Cited by-同舟云学术

CdGAP/ARHGAP31, a Cdc42/Rac1 GTPase regulator, is critical for vascular development and VEGF-mediated angiogenesis

Published:2016-06-07 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Caron Christine,DeGeer Jonathan,Fournier Patrick,Duquette Philippe M.,Luangrath Vilayphone,Ishii Hidetaka,Karimzadeh Fereshteh,Lamarche-Vane Nathalie,Royal Isabelle

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep27485.pdf

Reference61 articles.

1. Carmeliet, P. Angiogenesis in health and disease. Nat. Med. 9, 653–660 (2003).

2. Potente, M., Gerhardt, H. & Carmeliet, P. Basic and Therapeutic Aspects of Angiogenesis. Cell 146, 873–887 (2011).

3. Szekanecz, Z., Besenyei, T., Szentpétery, A. & Koch, A. E. Angiogenesis and vasculogenesis in rheumatoid arthritis. Curr. Opin. Rheumatol. 22, 299–306 (2010).

4. Annex, B. H. Therapeutic angiogenesis for critical limb ischaemia. Nat. Rev. Cardiol. 10, 387–396 (2013).

5. Chung, A. S. & Ferrara, N. Developmental and Pathological Angiogenesis. Annu. Rev. Cell Dev. Biol. 27, 563–584 (2011).

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of circRNA-miRNA-mRNA network related to angiogenesis in recurrent implantation failure;BMC Medical Genomics;2024-07-30

2. Rabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity;Cancer Gene Therapy;2024-07-29

3. Characterization of a New Variant in ARHGAP31 Probably Involved in Adams–Oliver Syndrome in a Family with a Variable Phenotypic Spectrum;Genes;2024-04-24

4. CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis;Cell Reports;2023-08

5. A DLG1-ARHGAP31-CDC42 axis is essential for the intestinal stem cell response to fluctuating niche Wnt signaling;Cell Stem Cell;2023-02